Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Germline determinants of risk and molecular subtype in young-onset lung cancer.
Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 24, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 06, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2026
MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2025
Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 26, 2025
Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000-2021.
Journal: Cancer
Published: September 12, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer Consortium.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 21, 2025
Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancers.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 01, 2025
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.
Journal: JAMA network open
Published: March 27, 2025
Last Updated: 09/26/2026